Clinical outcomes of patients with myelofibrosis after immediate transition to momelotinib from ruxolitinib.

Journal

Haematologica
ISSN: 1592-8721
Titre abrégé: Haematologica
Pays: Italy
ID NLM: 0417435

Informations de publication

Date de publication:
01 Jun 2023
Historique:
received: 09 03 2023
medline: 1 6 2023
pubmed: 1 6 2023
entrez: 1 6 2023
Statut: aheadofprint

Résumé

Not available.

Identifiants

DOI: 10.3324/haematol.2023.283106 PMID: 37259556
pubmed: 37259556
doi: 10.3324/haematol.2023.283106
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Ruben Mesa (R)

Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Wake Forest University School of Medicine, Winston Salem, NC. rmesa@wakehealth.edu.

Srdan Verstovsek (S)

The University of Texas MD Anderson Cancer Center, Houston, TX.

Uwe Platzbecker (U)

Leipzig University Hospital, Leipzig.

Vikas Gupta (V)

Princess Margaret Cancer Centre, Toronto, Ontario.

David Lavie (D)

Hadassah-Hebrew University Medical Center, Jerusalem.

Pilar Giraldo (P)

Miguel Servet University Hospital and Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Zaragoza.

Christian Recher (C)

Institut Universitaire du Cancer de Toulouse, Université de Toulouse III, Toulouse.

Jean-Jacques Kiladjian (JJ)

Université Paris Cité, AP-HP, Ho_pital Saint-Louis, Centre d'Investigations Cliniques, INSERM, CIC1427, Paris.

Stephen T Oh (ST)

Washington University School of Medicine, St. Louis, MO.

Aaron T Gerds (AT)

Cleveland Clinic Taussig Cancer Institute, Cleveland, OH.

Timothy Devos (T)

Department of Hematology, University Hospitals Leuven and Department of Microbiology and Immunology, Laboratory of Molecular Immunology (Rega Institute), KU Leuven, Leuven, Belgium.

Francesco Passamonti (F)

University of Insubria, Varese.

Alessandro M Vannucchi (AM)

University of Florence and AOU Careggi, Florence.

Miklos Egyed (M)

Somogy County Mór Kaposi General Hospital, Kaposvár, Hungary.

Ewa Lech-Maranda (E)

Institute of Hematology and Transfusion Medicine, Warsaw, Poland.

Andrzej Pluta (A)

Department of Hematological Oncology, Oncology Specialist Hospital, Brzozow, Poland.

Lars Nilsson (L)

Department of Hematology, Oncology and Radiation Physics, Skåne University Hospital, Lund, Sweden.

Kazuya Shimoda (K)

University of Miyazaki, Miyazaki, Japan.

Donal McLornan (D)

Guy's and St Thomas' NHS Foundation Trust, London.

Jun Kawashima (J)

Sierra Oncology, Inc., San Mateo, CA.

Barbara Klencke (B)

Sierra Oncology, Inc., San Mateo, CA.

Mei Huang (M)

Sierra Oncology, Inc., San Mateo, CA.

Bryan Strouse (B)

Sierra Oncology, Inc., San Mateo, CA.

Claire Harrison (C)

Guy's and St Thomas' NHS Foundation Trust, London.

Classifications MeSH